An approach to hypopigmentation

@article{Hill2017AnAT,
  title={An approach to hypopigmentation},
  author={Jeremy P. Hill and Jonathan M Batchelor},
  journal={British Medical Journal},
  year={2017},
  volume={356}
}
#### What you need to know Around 1 in 20 people have at least one hypopigmented macule.1 Patients may worry about pale patches and links to other disease. Hypopigmentation can be upsetting, particularly if visible. For people with darker skin, hypopigmentation may also result in stigma.2 Most causes of hypopigmentation are not serious, can be diagnosed clinically and may be treatable. This article aims to help non-specialists assess and treat patients with hypopigmented patches, focusing on… 
2 Citations
Scar Symptoms: Pigmentation Disorders
This chapter provides an overview of the epidemiology, pathophysiology, course, measurement, and potential therapies for pigmentation disorders in scars. Pigmentation problems are a common
Cutaneous Findings in Fanconi Anemia.

References

SHOWING 1-10 OF 14 REFERENCES
The psychosocial impact of vitiligo in Indian patients.
TLDR
Addressing psychosocial factors is an important aspect of the management of vitiligo, particularly in patients from communities where the disease is greatly stigmatizing.
Evidence-based Danish guidelines for the treatment of Malassezia-related skin diseases.
TLDR
Main recommendations in most cases of pityriasis versicolor and seborrhoeic dermatitis include topical treatment which has been shown to be sufficient, and systemic antifungal treatment is probably more effective than topical treatment but a combination may be favourable.
COMPARISON OF 0.05% CLOBETASOL PROPIONATE CREAM AND TOPICAL PUVASOL IN CHILDHOOD VITILIGO
TLDR
Fifty clinically diagnosed vitiligo patients under 12 years of age from the outpatient clinic of the Department of Dermatology, Mayo Hospital, Lahore, were included in this study and Chi-square tests were used for statistical analysis.
Pityriasis versicolor
Pityriasis versicolor is a common superficial fungal infection of the skin. It is caused by Malassezia spp., which are normal human saprophytes. Under certain conditions, both exogenous and
Circulating Autoantibodies and Autoimmune Comorbidities in Vitiligo Patients: A Multicenter Italian Study
TLDR
The prevalence of autoimmune comorbidities and circulating autoantibodies in this study was in agreement with other surveys conducted on Caucasian patients.
Halo nevi and melanoma.
TLDR
Halo nevi may occur in association with malignant melanoma more commonly than previously suspected and may represent an immune response to melanoma or related antigens.
Efficacy and safety of topical mometasone furoate 0.01% vs. tacrolimus 0.03% and mometasone furoate 0.01%in vitiligo
TLDR
It is recommended that topical mometasone has no role in the treatment of vitiligo in type IV skin but when combined with tacrolimus may potentiate its efficacy.
Clinical features and histological findings are potential indicators of activity in lesions of common vitiligo
TLDR
In the majority of common vitiligo cases, neither accurate clinical signs nor routine blood tests are available to determine whether or not the disease is active.
Evaluation of the effect of disease duration in generalized vitiligo on its clinical response to narrowband ultraviolet B phototherapy
TLDR
Evaluated the influence of disease duration on its clinical response to NB‐UVB phototherapy to find out whether different factors seem to contribute to a good response.
...
...